US Stock MarketDetailed Quotes

LABP Landos Biopharma

Watchlist
  • 22.4500
  • +0.2450+1.10%
Close May 14 16:00 ET
  • 22.3000
  • -0.1500-0.67%
Post 17:26 ET
70.18MMarket Cap-5612P/E (TTM)

Landos Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Landos Biopharma Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-1.43

-53.76%
Analyst Rating

Hold

Apr 1, 2024

Landos Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Landos Biopharma Earnings Reports

  • Landos Biopharma | 10-Q: Quarterly report

    May 9 20:37

  • Landos Biopharma | 10-K/A: Annual report (Amendment)

    Apr 16 20:05

  • Landos Biopharma | 10-K: Annual report

    Mar 21 20:36

  • Landos Biopharma: Q3 2023 Earnings Report

    Nov 9, 2023 21:22

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 1, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg